Loading company…
Stentys developed self-expanding stents for treating coronary artery disease.
Founded in 2006 and based in Paris, France, Stentys developed self-expanding stents for coronary artery disease. The company listed on NYSE Euronext Paris in October 2010, raising EUR 22.7 million through its IPO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in